Loading...
HSChapter 30
U.S. imports of chemical contraceptive preparations based on hormones (HS 300660) totaled $99.3M in April 2026, traded with 14 countries.
Last updated: April 2026 dataHormonal contraceptive preparations — including oral contraceptives, injectable formulations, and implantable or transdermal hormone-based products — are regulated by FDA as prescription drugs, requiring an approved NDA or ANDA before US importation. Finland and the Netherlands lead supply under this heading, reflecting the strong pharmaceutical manufacturing base in Northern Europe. The single 10-digit line (3006600000) encompasses the full range of hormone-based and spermicidal chemical contraceptives, so the regulatory pathway is driven by the specific active hormone or chemical agent rather than by tariff subheading distinctions. Cold-chain and controlled-substance handling requirements may also apply depending on the specific formulation.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
Hormonal contraceptives are prescription drugs regulated by FDA's Center for Drug Evaluation and Research. The importer must ensure the product has an approved New Drug Application (NDA) or Abbreviated NDA (ANDA) and that the foreign manufacturer is registered with FDA and listed on the drug establishment registration. Shipments from unapproved establishments are subject to refusal of admission. Consult a licensed customs broker or regulatory counsel to confirm specific admissibility requirements.
Heading 3006.60 covers chemical contraceptive preparations based on hormones, other hormonal products, or spermicides. A combination product is generally classified here if its contraceptive function is the essential character, regardless of whether it contains both hormonal and non-hormonal active ingredients. The specific formulation should be reviewed against Chapter 30 notes and any applicable CBP rulings to confirm the correct heading.
Supplier Network
Get discovered by U.S. importers searching for HS 300660 — Chemical Contraceptive Preparations Based on Hormones. Be the first supplier listed.
Monthly import values over time
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % |
|---|---|---|---|
| 3006600000 | CHEMICAL CONTRACEPTIVE PREPS BASED ON HORMONES ETC | $99.3M | -- |
CHEMICAL CONTRACEPTIVE PREPS BASED ON HORMONES ETC
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3006600000 | CHEMICAL CONTRACEPTIVE PREPS BASED ON HORMONES ETC | $99K |
CHEMICAL CONTRACEPTIVE PREPS BASED ON HORMONES ETC
1.3K kg
MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI
HS 300490
IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE
HS 300215
VACCINES FOR HUMAN MEDICINE
HS 300241
HORMONES ETC. (NO ANTIBIOTICS CONTAINED) DOSAGE FM
HS 300439
ANTISERA AND OTHER BLOOD FRACTIONS
HS 300212
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| State | Imports | Exports | Balance |
|---|---|---|---|
| Pennsylvania | $70.7M | $3K | -$70.7M |
| Illinois | $17.4M | -- | -$17.4M |
| New Jersey | $3.5M | -- | -$3.5M |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| ALEXANDRIA BAY, NY | $25.9M | -- | -$25.9M |
| CHAMPLAIN-ROUSES POINT, NY | $21.0M | -- | -$21.0M |
| BUFFALO-NIAGARA FALLS, NY | $20.7M | $23K | -$20.7M |